Small-vessel Disease Burden and Early Risk of Stroke After Transient Ischemic Attack

2019-10-03 07:54:38 | BioPortfolio


Predicting the risk of stroke remains a challenge in the management of transient ischemic attack (TIA). In addition to clinical variables, morphological features such as the presence of a diffusion weighted sequence (DWI) lesion and carotid stenosis of at least 50% improve risk stratification and are considered in the literature. score ABCD3-I1. Several studies have shown that brain microhemorrhages are associated with the risk of early stroke in patients with TIA. Data on white matter hypersignals on the T2-weighted sequence or FLAIR (FLuid Attenuated Inversion Recovery) are more conflicting. The global microangiopathic load, including the gaps, the hypersignals of the white matter, the perivascular spaces visible on MRI in the basal ganglia, especially when they are very numerous (> 20) and the gaps, have recently been described as being associated with stroke risk within 2 to 3 years of TIA or ischemic stroke. To date, the predictive value of global microangiopathic burden on early stroke risk in the course of TIA is not known.

Study Design


Diagnosis of TIA


microangiopathic burden


Hospices Civils de Lyon




Hospices Civils de Lyon

Results (where available)

View Results


Published on BioPortfolio: 2019-10-03T07:54:38-0400

Clinical Trials [350 Associated Clinical Trials listed on BioPortfolio]

Implications for Management of PET Amyloid Classification Technology

The main purpose of this study is to explore the impact of an amyloid positron emission tomography and computed tomography (PET/CT) scan on physician diagnosis and management, including dr...

Artificial Intelligence in Children's Clinic

At the third-class hospital in China, outpatients are in the majority and doctors have a heavy workload. Therefore, the phenomenon of long waiting time and short treatment time seems to be...

Control and Burden of Asthma and Rhinitis

An observational cross-sectional study will include 750 individuals of all ages, divided in 4 groups: 1) Patients with a self-reported diagnosis of asthma alone (n=150), 2) Patients with a...

Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease

The aim of this non-investigational study is to determine the symptoms and disease burden at the time point of diagnosis and in the further course of an incurable cancer disease. The needs...

The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania

This study aims to compare the burden of neurocysticercosis among people living with HIV to people not infected with HIV.

PubMed Articles [8622 Associated PubMed Articles listed on BioPortfolio]

Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis.

Understanding the burden of Crohn's disease (CD) and ulcerative colitis (UC) is important for measuring treatment value. We estimated lifetime healthcare costs incurred by patients with CD or UC by ag...

Pregnancy Prolongation After Eculizumab Use in Early-Onset Preeclampsia.

Untreated microangiopathic hemolytic anemia in pregnancy is associated with adverse maternal and perinatal outcomes. Accurate diagnosis is challenging owing to nonspecific clinical features and pathol...

Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.

In myeloproliferative neoplasms (MPN), JAK2V617F allele burden measurement has an impact on prognosis that helps in patient monitoring. Less is known about its usefulness in CALR-mutated cases. Additi...

Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis.

The diagnosis of osteoarticular tuberculosis (TB) remains challenging and results in under- or over-diagnosis. The aim of the present study was to evaluate performance of the novel next-generation Xpe...

High NPM1 Mutant Allele Burden at Diagnosis Correlates with Minimal Residual Disease at First Remission in De Novo AML.

Acute myeloid leukemia (AML) with mutated NPM1 is a newly recognized separate entity in the revised 2016 WHO classification, and is associated with a favorable prognosis. While previous studies have e...

Medical and Biotech [MESH] Definitions

Measure of the burden of disease using the disability-adjusted-life-year (DALY). This time-based measure combines years of life lost due to premature mortality and years of life lost due to time lived in states of less than full health. The metric was developed to assess the burden of disease consistently across diseases, risk factors and regions.

Administration of a medication to at-risk individuals in a population without individual diagnosis. It is often used in order to treat, control, and/or prevent spread of often endemic DISEASE OUTBREAKS such as NEGLECTED DISEASES in high disease burden areas.

The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal.

The total amount (cell number, weight, size or volume) of tumor cells or tissue in the body.

Examination of the mouth and teeth toward the identification and diagnosis of intraoral disease or manifestation of non-oral conditions.

More From BioPortfolio on "Small-vessel Disease Burden and Early Risk of Stroke After Transient Ischemic Attack"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Searches Linking to this Trial